TY - JOUR
T1 - Filter assay for 1α, 25-dihydroxyvitamin D3. Utilization of the hormone's target tissue chromatin receptor
AU - Brumbaugh, Peter F.
AU - Haussler, David H.
AU - Bursae, Kristine M.
AU - Haussler, Mark R.
PY - 1974/9/1
Y1 - 1974/9/1
N2 - A radioreceptor assay for 1α, 25-dihydroxyvitamin D3 (1α, 25-(OH)2-D3) has been developed by utilizing competitive binding to the receptor system from chick intestinal mucosa. This target tissue binding system consists of a high affinity cytosol receptor protein and acceptor sites on nuclear chromatin. Reconstituted cytosol-chromatin is incubated with radioactive 1α, 25-(OH)2-D3, and the bound and free sterol are separated by trapping the hormone-receptor-chromatin complex on glass fiber filters. Washing away of free or nonspecifically bound sterol is carried out with 1% Triton X-100. The amount of specifically bound sterol is linearly related to the quantity of cytosol-chromatin in the incubation and the receptor system is saturated at 5 nM la, 25-(OH)2-[3H]D3. An isotope-dilution standard curve obtained with increasing amounts of authentic nonradioactive 1α, 25-(OH)2-D3 indicates that 17 pg of hormone can be detected by this assay. After extraction and extensive purification of the suspected 1α, 25-(OH)2-D3 fraction from normal chick and human plasma, the circulating levels of the hormone were determined to be 8.0 and 4.0 ng/100 ml, respectively. These values were verified by demonstrating that the assayable material elutes with tracer 1α, 25- (OH)2-[3H]D3 on Celite liquid-liquid partition columns. By similar analysis, rachitic chick plasma contained <0.05 ng of 1α, 25-(OH)2-D3/100 ml. The lower limit of sensitivity of the assay for human plasma samples (20 ml) is 1.0 ng/100 ml of 1α, 25-(OH)2-D3 and the coefficient of variation is 12%. Patients with chronic renal failure and anephric subjects have undetectable circulating levels of the kidney-produced la, 25- (OH)2-D3 hormone as determined by the assay. These data implicate a lack of 1α, 25-(OH)2-D3 in the etiology of renal osteodystrophy and point to the kidney as the unique site of synthesis of 1α, 25-(OH)2-D3 in humans. This assay should not only be of great utility in diagnosing other defects in vitamin D metabolism, but the concept of employing the two-step receptor binding system for the sterol may find application in the assay of steroid hormones.
AB - A radioreceptor assay for 1α, 25-dihydroxyvitamin D3 (1α, 25-(OH)2-D3) has been developed by utilizing competitive binding to the receptor system from chick intestinal mucosa. This target tissue binding system consists of a high affinity cytosol receptor protein and acceptor sites on nuclear chromatin. Reconstituted cytosol-chromatin is incubated with radioactive 1α, 25-(OH)2-D3, and the bound and free sterol are separated by trapping the hormone-receptor-chromatin complex on glass fiber filters. Washing away of free or nonspecifically bound sterol is carried out with 1% Triton X-100. The amount of specifically bound sterol is linearly related to the quantity of cytosol-chromatin in the incubation and the receptor system is saturated at 5 nM la, 25-(OH)2-[3H]D3. An isotope-dilution standard curve obtained with increasing amounts of authentic nonradioactive 1α, 25-(OH)2-D3 indicates that 17 pg of hormone can be detected by this assay. After extraction and extensive purification of the suspected 1α, 25-(OH)2-D3 fraction from normal chick and human plasma, the circulating levels of the hormone were determined to be 8.0 and 4.0 ng/100 ml, respectively. These values were verified by demonstrating that the assayable material elutes with tracer 1α, 25- (OH)2-[3H]D3 on Celite liquid-liquid partition columns. By similar analysis, rachitic chick plasma contained <0.05 ng of 1α, 25-(OH)2-D3/100 ml. The lower limit of sensitivity of the assay for human plasma samples (20 ml) is 1.0 ng/100 ml of 1α, 25-(OH)2-D3 and the coefficient of variation is 12%. Patients with chronic renal failure and anephric subjects have undetectable circulating levels of the kidney-produced la, 25- (OH)2-D3 hormone as determined by the assay. These data implicate a lack of 1α, 25-(OH)2-D3 in the etiology of renal osteodystrophy and point to the kidney as the unique site of synthesis of 1α, 25-(OH)2-D3 in humans. This assay should not only be of great utility in diagnosing other defects in vitamin D metabolism, but the concept of employing the two-step receptor binding system for the sterol may find application in the assay of steroid hormones.
UR - http://www.scopus.com/inward/record.url?scp=0016139221&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0016139221&partnerID=8YFLogxK
U2 - 10.1021/bi00717a005
DO - 10.1021/bi00717a005
M3 - Article
C2 - 4370023
AN - SCOPUS:0016139221
SN - 0006-2960
VL - 13
SP - 4091
EP - 4097
JO - Biochemistry
JF - Biochemistry
IS - 20
ER -